An update on Dendritic Cell-Based Cancer Immunotherapy

  title={An update on Dendritic Cell-Based Cancer Immunotherapy},
  author={S. Shimodaira and Koichi Hirabayashi and T. Koya and Y. Higuchi and R. Yanagisawa and Masato Okamoto and S. Koido},
  journal={Immunome Research},
  • S. Shimodaira, Koichi Hirabayashi, +4 authors S. Koido
  • Published 2016
  • Medicine
  • Immunome Research
  • Although treating advanced cancers that affect organs with distant metastasis remains challenging, the pace of recent advances has accelerated; these advances have particularly focused on the inhibitors of key immune potentiates. Research on therapeutic vaccination involving active dendritic cell (DC)-based immunotherapy is also being performed for the induction of an effi cient immune response against cancer-associated antigens by the acquired immune system. Cancer vaccines prepared with… CONTINUE READING
    3 Citations


    Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death
    • 204
    • PDF
    The feasibility and clinical effects of dendritic cell-based immunotherapy targeting synthesized peptides for recurrent ovarian cancer
    • 34
    The First 1000 Dendritic Cell Vaccinees
    • 288
    Tumor immunotherapy directed at PD-1.
    • A. Ribas
    • Medicine
    • The New England journal of medicine
    • 2012
    • 473
    • PDF
    Dendritic Cell-Based Immunotherapy Targeting Synthesized Peptides for Advanced Biliary Tract Cancer
    • 50
    Clinical Impact of Checkpoint Inhibitors as Novel Cancer Therapies
    • 80
    • PDF
    Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion
    • 318
    • PDF
    Immunotherapy Converts Nonimmunogenic Pancreatic Tumors into Immunogenic Foci of Immune Regulation
    • 271
    • PDF
    Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy
    • 121
    • PDF